Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Short term Debt (2019 - 2025)

Volitionrx (VNRX) has disclosed Short term Debt for 8 consecutive years, with $319347.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short term Debt fell 66.91% year-over-year to $319347.0, compared with a TTM value of $319347.0 through Sep 2025, down 66.91%, and an annual FY2023 reading of $1.2 million, up 13.15% over the prior year.
  • Short term Debt was $319347.0 for Q3 2025 at Volitionrx, down from $1.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $1.3 million in Q1 2022 and bottomed at $319347.0 in Q3 2025.
  • Average Short term Debt over 5 years is $1.0 million, with a median of $1.1 million recorded in 2022.
  • The sharpest move saw Short term Debt skyrocketed 40.19% in 2022, then crashed 66.91% in 2025.
  • Year by year, Short term Debt stood at $797855.0 in 2021, then skyrocketed by 33.7% to $1.1 million in 2022, then increased by 13.15% to $1.2 million in 2023, then dropped by 20.05% to $965021.0 in 2024, then plummeted by 66.91% to $319347.0 in 2025.
  • Business Quant data shows Short term Debt for VNRX at $319347.0 in Q3 2025, $1.0 million in Q2 2025, and $862475.0 in Q1 2025.